Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Protein Predicts Response To New Immunotherapy Drug
Friday, November 28, 2014
Trial shows that response to treatment may be predicted by the presence of an immune-suppressing protein in non-cancerous immune cells.

A Hybrid Vehicle That Delivers DNA
Thursday, November 27, 2014
University at Buffalo researchers are developing new technology to improve DNA vaccines. The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.

New Study Reveals Why Some People May be Immune to HIV-1
Wednesday, November 26, 2014
Natural genetic variation in a protective antiviral enzyme holds promise for new therapies.

Merck Announces Global Strategic Alliance with Pfizer
Tuesday, November 25, 2014
Merck and Pfizer will jointly develop and commercialize Merck’s anti-PD-L1.

Bacterial Toxin Targets Discovered
Tuesday, November 25, 2014
Understanding how bacterial toxins target human cells is set to have major implications for the development of novel drugs.

Monitoring Effectiveness Of Hay Fever Immunotherapy
Monday, November 24, 2014
A new test for measuring histamine release from certain white blood cells could help doctors monitor the effectiveness of immunotherapy for hay fever.

Precisely Off The Mark
Monday, November 24, 2014
Possible cause discovered for failure of targeted liver cancer therapies.

Drugs to Block Angiogenesis Could Provide New Treatment for TB
Monday, November 24, 2014
Blood supply gives invaders oxygen and a way out.

Researchers Tease Out Glitches in Immune System's Self-Recognition
Saturday, November 22, 2014
A new study revises understanding of how the process works and sheds light on autoimmune disease.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1259
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv